摘要
目的
对过敏体质的相关文献进行梳理,分析古代及现代对过敏体质的认识,补充中医体质学过敏体质相关理论;采用基因芯片技术,对过敏体质者的外周血基因表达谱进行研究,探讨过敏体质分子生物学特征,为过敏体质的辨识和防治,提供理论及实验依据。
方法
梳理分析古今文献中有关过敏体质的论述,在中医体质学对过敏体质的概念、成因、特征、诊断、干预方法论述的基础上,补充过敏体质的相关理论。
在临床流行病学调查的基础上,按过敏体质标准,挑选30例平和体质者和15例过敏体质者,对其进行常规体检、中医症状体征调查。取上述受试者的外周血,提取总RNA并进行扩增和标记,用Sentrix(?) Human-6 Expression BeadChip检测受试样品,并将所得数据进行统计学分析,对差异表达基因进行GO注释和pathway分析,并对差异表达基因的生物学功能进行评价,阐述部分差异表达基因及其相关通路与过敏体质的关系,从基因水平探讨过敏体质成因、特征及其发病机制。
结果
中医古代文献尚未形成对过敏体质的系统论述,中医体质学明确提出过敏体质的概念并对过敏体质防治有突破性认识。中医体质学认为对过敏体质者调治的重点应该是针对“过敏人”,而不是一味避开“过敏原”,对于具有过敏体质而未发病的人群,积极改善其过敏体质,可实现病因预防。
基因表达谱研究发现,过敏体质者与平和体质者相比,外周血基因表达谱上调的基因有86个,下调的基因有111个。其中FOS基因、IL-16基因表达的上调与近期对其与过敏的相关研究结果相一致;而其他表达差异的基因中,涉及的生物信息学通路与过敏关系密切的有IL-4signaling pathway及p38MAPK signaling pathway等,差异表达基因在上述生物信息学通路中起重要作用,可能在过敏体质发生过敏性疾病的过程中起重要调节作用。
结论
基于中医体质学理论的过敏体质调治思想,对于阻止过敏体质相关过敏性疾病的发生、发展,具有重要的指导意义;过敏体质者与平和体质者相比FOS基因、IL-16基因表达的差异是其基因水平的重要表现;其他表达差异参与IL-4signaling pathway及p38 MAPK signal ing pathway的调节过程,与过敏体质发生过敏性疾病有密切关系。
Objective:
Analysis the ancient and modern recognition by Sorting pertinent literature,Supplement and consummate the theory system of the Allergic constitution;Study the peripheral blood gene expression profile of the Allergic constitution by gene chip technique.Not only providing theory and experiment support for identifying the Allergic constitution but also for the prevention and treatment of hypersensitivity disease.
Methods:
Analysis the ancient and modern recognition by Sorting pertinent literature,Discuss concept,source,characteristic,diagnosis,intervention of The Allergic constitution deeply.Supplement and consummate the theory system of the Allergic constitution;15 cases of the Allergic constitution and 30 cases of the Balanced constitution were selected by the standard of the Allergic constitution and the Blanced constitution.The regular physical examination,TCM symptoms and syndromes were investigated accordingly.Total RNA was extracted from peripheral blood,and it was amplified and labeled.The sample were checked by Sentrix(?) Human-6 Expression Bead Chip.The data was analyzed and the gene symbols with significant difference were searched in GENE BANK database.the gene differential expression profiles and correlated pathway were analyzed.
Results:
"Allergic constitution "has not been found in ancient literature of TCM.The constitutions of TCM bring new ideas to the recognition of the the Allergic constitution.it considered the emphasis of medical care to the Allergic constitution is not the sensitinogen but the human being who suffer from hypersensitivity disease.The results showed that the peripheral blood gene expression levels were different in the Allergic constitution Comparing with the Blanced constitution,There were 86 genes expression up-regulated and 111 genes expression down-regulated.Fos gene and IL-16 gene up-regulated among the total,the result have resemblance with the findings about fos gene and IL-16 gene recently;several gene have intimate relationship with the IL-4signaling pathway and p38 MAPK signalilng pathway,the findings is valuable for the learning of the Allergic constitution to TCM.
Conclusions:
The sought about prevention and cure to the Allergic constitution based on the theory of The constitutions of TCM.it benefits the prevention and treatment of hypersensitivity disease.The peripheral blood gene differential expression profiles in the Allergic constitution was found for the first time.Fos gene and IL-16 gene up-regulating and several gene having intimate relationship with the IL-4signaling pathway and p38 MAPK signalilng pathway maybe the characteristic of the Allergic constitution,
引文
[1]王琦主编.中医体质学[M].北京:中国医药科技出版社,1995:11.
[2]巢元方等。 诸病源候论[M].北京:人民卫生出版社,1955:189,214。
[3]清·吴谦等编.医宗金鉴(下册)[M].北京:人民卫生出版社,1985:1889.
[4]清·吴谦等编.医宗金鉴(下册)[M].北京:人民卫生出版社,1985:1997。
[5]清·方隅.医林绳墨[M].北京:商务印书馆.1957:120.
[6]王琦.中医体质学[M].北京:人民卫生出版社,2005:72.
[7]王琦,骆庆峰.过敏体质的概念、形成与调控原理[J]。北京中医药大学学报,2004,27(2):6。
[8]王琦.中医体质学[M].北京:人民卫生出版社,2005:72.
[9]苏俊,王琦,钱会南,等.特禀体质特点初步研究[J].辽宁中医杂志,2008,35(6):824.
[10]叶世泰.变态反应学[M].北京:科学出版社,1998:132.
[11]陈慧敏,蒋卓勤.不同水平维生素A对哮喘豚鼠IL-5和IgE的影响[J].广东医学,2006,27(9):1294-1296.
[12]王琦,王睿林,李英帅.中医体质学学科发展述评[J].中华中医药杂志,2007,22(9):627-630.
[13]孙淑芬。从瘀热论治过敏性紫癜102例[J].北京中医药大学学报,2001,24(6):70-71.
[14]张咏梅,活血化瘀法治疗过敏性紫癜临床观察[J]。天津中医,1999,16(6):36-37.
[15]唐莉珍.辨证治疗过敏性紫癜60例[J].实用中医药杂志,2002,18(8):10.
[16]张小平,钱育寿.辨治过敏性紫癜6法[J].江苏中医药,2003,24(1):75.
[17]阎丰书.清癜合剂治疗过敏性紫癜57例疗效观察[J].新中医,2003,11(38):29-30.
[18]吴成山.过敏性鼻炎以痰论治初探[J],陕西中医,1996,17(12):54.
[19]王士贞。中医耳鼻喉科学[M].北京:中国中医药出版社,2003:125-127.
[20]张国雄。中药治疗过敏性鼻炎的体会[J].实用中医药杂志,2004,20(3):151.
[21]孙英.中药治疗荨麻疹的疗效观察[J].辽宁中医,2002,29(3):157.
[22]刘和平。自拟扶正祛风汤治疗荨麻疹265例临床观察[J].北京中医,2000,19(4):25.
[23]吴绪祥.抗敏汤治疗荨麻疹46例[J].河北中医,2000,22(2):127。
[24]刘志芬.自拟荨麻疹汤治疗慢性荨麻疹40例[J].四川中医,2000,18(8):34.
[25]许光兰.十味龙胆花颗粒治疗咳嗽变异型哮喘63例[J]。 中国中医药信息杂志,2002,9(1):72.
[26]Cook PR,Nishioka GJ.Allergic rhinosinusitis in the pediatric population[J].Otolaryngol Clin North Am,1996,29(1):39-56.
[27]王琦,骆庆峰,过敏体质的概念、形成与调控原理[J].北京中医药大学学报,2004,27(2):6.
[28]靳琦.王琦辨体-辨病-辨证诊疗模式[M].中国中医药出版社,2006:53.
[29]骆庆峰,王琦,牛欣。过敏康Ⅱ号胶囊对NIH雄性小鼠血清抗精子抗体的影响[J].北京中医药大学学报,2003,26(3):41-43.
[1]Zhang Y,Leaves NI,Anderson GG,et al.Positional cloning of a quantitative trait locus on chromosome 13q14 thatinfluences immunoglobulin E levels and asthma[J].NatGenet,2003,34(2):181-186.
[2]Torres-Galvan MJ,Quiralte J,Pestano JJ,et al.IL4-R1(5q31-q33) and FcepsilonRI-betaca(11q13) markers and atopy:a case/control study in a spanish population[J].Allergy,2001,56(2):159-163.
[3]Demoly P.Respiratory allergic disease genes[J].RevPneumol Clin,2003,59(2 Pt 1):67-75.
[4]Malerba G,Pignatti PF.A review of asthma genetics:geneexpression studies and recent candidates[J].J Appl Genet,2005,46(1):93-104.
[5]邢志敏,于德林,安淑兰.蒿属花粉过敏过敏性鼻炎与HLA-DQA1、DQB1基因的关系[J].临床耳鼻咽喉科杂志,2002,16(12):678.
[6]GurjitK,Khurana H,Michal F,et al.The association of atopy with gain-of-function mutation in theαsubunit of the interleukin-4 receptor[J].New Engl J Med,1997,337:1720-1725.
[7]Biumenthal M,Bjorksten B.Genetic studies of asthma and allergy:Methods for investigative studies[J].NewYork:Marcel Dekker Inc,1997.167-178.
[8]Marsh DG,Neely JD,Breazeale DR,et al.Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations[J].Science,1994,264:1152-1156.
[9]Deichmann KA,Heinzmann A,Forster J,et al.Linkage and allelic association of atopy and markers flanking the IL-4-receptor gene[J].Clin Exp Allergy,1998,28:151-155.
[10]Takabayashi A,Ihara K,Sasaki Y,et al.Childhood atopic asthma:positive association with a polymorphism of IL-4 receptor alpha gene but not with that of IL-4 promoter or Fc epsilon receptor I beta gene[J].Exp Clin Immunogenet,2000,17:63-70.
[11]Kruse S,Japha J,Tedner M,et al.The polymorphisms S503P and Q576R in the interleukin-4 receptor alpha gene are associated with atopy and influence the signal transduction[J].Immunology,1999,96:365-371.
[12]Lee SG,et al.Gene-gene interaction between interleukin-4 and interleukin-4 receptor alpha in Korean children with asthma.[J].Clin Exp Allergy,2004,34:1202-1208.
[13]Andrews RP,Burrell L,Rosa-Rosa L,et al.Analysis of the Ser786Pro interleukin-4 receptor alpha allelic variant in allergic and nonallergic asthma and its functional consequences[J].Clin Immunol.2001 Sep;100(3)::298-304.
[14]Rosa-Rosa L,et al.The R576 IL-4 receptor.alpha,allele correlates with asthma severity[J].Allergy Clin.Immunol.(1999) 104:1008-1014.
[15]潘世秀,崔天盆,吴健民.白介素4受体α链基因多态性与哮喘易感性的相关性研究[J].中华检验医学杂志,2002,25(4):229.
[16]Lee YC,et al.Serum levels of interleukins(IL)-4,IL-5,IL-13 and interferon-gamma in acute asthma[J].J Asthma,2001,38..665 -671.
[17]Taro S,et al.Atopy and asthma:genetic variants of IL-4 and IL-13signaling.[J].Immunology Today,2000;21:60-64.
[18]HowardTD,et al.Identification and association of polymorphisms in the interleukin 13 gene with asthma and atopy in a Dutch population[J].Am J Respir Cell Mol Biol,2001,25:377-384.
[19]姜晓峰,等.分子信标毛细管电泳技术联合检测哮喘患者白细胞介素13基因多态性[J].中华检验医学杂志,2004,27(4):7-10.
[20]Dent LA,Strath M,Mellor AL,et al.Eosinophilia in Transgenic Mice Expressing Interleu Kin5.J Eep Med,1990,172:1425
[21]张齐武,陈萍,林小平.过敏性哮喘患者外周血单个核细胞白细胞介素6mRNA基因表达与血清sIgE水平相关性研究[J].中华结核和呼吸杂志,1999,22(11):702
[22]Noguchi E,et al.Association between TNFA polymorphism and the development of asthma in the Japanese population[J].Am J Respir Crit Care Med 2002;166:43-46.
[23]翟芳芝,等.肿瘤坏死因子-α基因多态性与支气管哮喘相关性研究[J].山东医药,2004,44(25):4-6.
[24]Li YF,et al.Intercellular adhesion molecule-1 and childhood asthma[J].Hum Genet 2005;117:476-484.
[25].Kimura K,Noguchi E.Linkage and association of atopic asthma to markers on chromsome 13 in the Japanese population[J].Hun Mol Gene,1999,8(8):1487-1490.
[26].Postma DS.The genetics of atopy and airway hyperresponsiveness[J].Am J Respir Crit Care Med,2000,162:118-123.
[27].Noguchi E,Shibasaki M,Arinami T,et al.Evidence for linkage between asthma/ atopy in childhood and chromosome 5q31 -33in a Japanese population[J].Am J Respir Crit Care Med,1997,156..1390-1393.
[28].Schiby P,Umland RP.Schleimer L,et al.Review of the molecular and cellular mechanisms of action of glucocorticoids for use in asthma[J].Pulmonary Pharmacol Ther,2002,15:35-50.
[29]Bignon J S,Aron Y,JULY,eta.l HLA class Ⅱ alleles in isocya-nate-induced asthma[J].Am JRespirCritCareMed,1994,149(1):71-5.
[30]Soriano J B,Ercilla G,Sunyer J,eta.l HLA class Ⅱ genes in soybean epidemic asthma patients[J].Am J Respir Crit CareMed,1997,156(5):1394-8.
[31]Gao JM,Lin Y G,Qiu C C,et a.lAssociation between HLA-DQA1,-DQB1 gene polymorphisms and susceptibility to asthma innorthern Chinese subjects[J].ChinMed J,2003,116(7):1078-82.
[32]EDER W,KLIMECKI W,YU L,et al.Toll-like Receptor 2 as a Major Gene for Asthma in Children of European Farmers[J].J Allergy Clin Immunol,2004,113(3):482-488.
[33]汤彦,吴晓琴,刘晓妍.高亲和度IgE受体β链基因多态性与过敏性哮喘相关性的研究[J].中国现代医学杂志,2003,13(9):6.
[34]徐青,邓伟吾,李伟杰.TAP1基因和Fc ε RIβ基因多态性与哮喘及其表型的相关性研究[J].中国免疫学杂志,2001,17(4):212.
[35]赵凯姝,鲁继荣,王振华.Fc ε R I-β基因启动子区多态性与哮喘儿童血清总IgE的关系[J].中国实用儿科杂志2004 19(12):744.
[36]Giovanni M,Malerba G,Pignatti PF.et al.A review of asthma genetics:gene expression studies and recent candidates[J].J Appl Genet,2005,46:93-104.
[37]Noguchi E,et al.New polymorphisms of haematopoietic prostaglandin D synthase and human prostanoid DP receptor genes[J].Clin Exp All,2002,32:93-96.
[38]Oguma T,et al Role of prostanoid DP receptor variants in susceptibility to asthma.[J].N Engl J Med,2004,351:1752-1763.
[39]Giovanni M,Malerba G,Pignatti PF.et al.A review of asthma genetics:gene expression studies and recent candidates[J].J Appl Genet,2005,46:93-104.
[40]Benjamin AR,et al.Association of vitamin D receptor gene polymorphisms with childhood and adult asthma[J].Am J Respir Crit Care Med,2004,170:1057-1065.
[41]Poon AH,et al.Association of vitamin D receptor genetic variants with susceptibility to asthma and atopy[J].Am J Respir Crit CareMed,2004,170:967-973.
[42]Heiko H,Marsha WK,Christopher L,et al.The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma[J].Mol Immunol,2004,41:123-131.
[43]Israel E,Drazen JM,Liggett SB,et al.The effect of polymorphism of theβ2_ adrenergic receptor to regular use of albuteral in asthma[J].Int Arch Allergy Immunol,2001,124(1):183-186.
[44]van Eerdewegh P,et al.Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness[J].Nature,2002,418:426-430.
[45]Howard TD,et al.Association of a disintegrin and metalloprotease 33(ADAM33) gene with asthma in ethnically diverse populations[J].J Allergy Clin Immunol,2003,112:717-722.
[46]Zhang Y,et al.Positional cloning of a quantitative trait locus on chromosome 13q14 that influences immunoglobulin E levels and asthma[J].Nat Genet,2003,34:181-186.
[47]樊卫文,杨志军,孙滨.过敏性哮喘大鼠大脑和肺组织c-fos蛋白的表达(c-fos原癌基因)[J].中华结核和呼吸杂志2001,24(8):469.
[48]Yang IA,Barton SJ,Rorke S,et al.Toll-like Receptor4 Polymorphism and Severity of Adopy in Asthmatics[J].Genes Immun,2004,5(1):41-45.
[49]Werner M,Topp R,Wimmer K,et al.TLR4 Gene Va-riants Modify Endotoxin Effects on Asthma[J].J Allergy Clin Immunol,2003,112(2):323-330.
[50]王利君,李一荣,陈建华.过敏性支气管哮喘儿童正常T淋巴细胞表达和分泌的活性调节蛋白基因启动子-28位基因多态性研究[J].中华结核和呼吸杂志,2004,27(6):394.
[51]李波,韩宏志,李善玉.亚甲基四氢叶酸还原酶基因多态性与儿童支气管哮喘的相关性[J].疾病控制杂志2005,9(6):548.
[52]Nyulassy S,BucM,sasinkaM,et al.The HLA systemin glomerulonephritis[J].Clin Immunol Immunopahol,1977;7(3):319-323.
[53]Jin DK,KohsakaT,koo JW,et a.l.Complement4 locus Ⅱ gene deletion and DQA1* 0301 gene:genetic risk factors for IgA nephropathy and Henoch-Schonlein nephritis[J].Nephron,1996;73(3):390-395.
[54]DongKJ,TaKaoK,JaWK,et a.l Complement4 locusll gene deletion and DQA1 0301 gene:Genetic risk forIgA nephropatgy and Henoch Schnlein nephritis[J].Nephron,1996;73:390.
[55]任少敏,杨光路,仝林虎.蒙古族儿童过敏性紫癜及其器官损害与HLA-DRB1等位基因的关联性[J].中国基层医药2005,12(12):1659.
[56]Stefansson Thors V,Kolka R,Sigurdardottir SL,et al Increased frequency of C4B* Q0 alleles in patients with Henoch-Schonlein purpura[J]..Scand J Immunol,2005,61(3):274-278.
[57]于慧玲,屠军,夏养志.HLA-DRB1等位基因与内蒙古汉族儿童过敏性紫癜相关性的研究[J].内蒙古医学院学报,2005,27(4):287.
[58]Groene HJ,Schwabe GC,Walther,et al.Expression of de-velopmental control genes PAX2 and PAX8 in adult kidney andduring regeneration of renal tubular epithelium[J].J Am SocNephrol,1993,4(2)..465.
[59]Quaggin SE.Transcriptional regulation of podocyte specifica-tion and differentiation[J].Microsc Res Tech,2002,57(4):208-211.
[60]Ohtaka A,Ootaka T,Sato H,et al.Phenotypic change of glomerular podocytes in primary focal segmental glomerulosclerosis:developmental paradigm [J].Nephrol Dial Transplant,2002,17(Suppl 9):11.
[61]Yang Y,Gubler MC,Beaufils H.Dysregulation of podocytephenotype in idiopathic collapsing glomerulopathy and HIV-as-sociated nephropathy[J].Nephron,2002,91(3):416-423.
[62]朱翠平,易著文,党西强.PAX2在紫癜性肾炎患儿肾组织的表达及其临床意义[J].医学临床研究,2005,22(11):1514.
[63]Yi ZW,FangXL,WuXC,eta.l Role ofPAX2 gene polymorphisms in Henoch-Schonlein purpura nephritis[J].Nephrology(Carlton),2006,11(1):42-48.
[64]林瑞霞,杨青,杨宇真.ACE基因多态性与儿童过敏性紫癜的关系[J].浙江医学,1999,21(3):136.
[65]Zhou J,Tian X,Xu Q Angiotensin-converting enzyme gene inser-tion/deletion polymorphism in children with Henoch-Schonlein purpua nephritis[J].J Huazhong Univ Sci Technolog Med Sci,2004,24(2):158.
[66]张慧玉,刘瑞兰,庞保东.血小板活化因子分解酶基因多态性在儿童过敏性紫癜中的意义[J]实用医学杂志,2006,22(3):303
[67]van der Pouw KraanTC,van Veen A,Boeije LC,et al IL-13Promoter polymophism associated with increased risk of allergic asthma[J].Genes Immun1999,1:61-65.
[68]Arima K,Umeshita Suyama R,Sakata Y,et al.Upregulation of IL-13Concentration in vivo by the IL-13 variant associated with bronchial asthma[J].Allergy Clin Immunol,2002,109:980-987.
[69]Howard TD,Whittaker PA,Zaiman AL,et al.Identification and association of polymorphisms in the interleukinl3 gene with asthma and atopy in a Dutch population[J].Am J Respir Cell Mol Biol,2001,25:377-384.
[70]Liu X,Nickel R,Beyer K,etal.An IL-13 coding region variant is associated with a high total serum IgE level and atopic dermatitis in the German multicenter atopy study(MAS-90)[J].J Allergy Clin Immunol,2000,106:167-170.
[71]Leung TF,Tang NL,Chan IH,etal.Apolymorphism in the coding region Of interleukin 13 gene is associated with atopy but not asthma in Chinese children[J].Clin Exp Allergy,2001,31:1515-1521.
[72]Hershey GK,Friedrich MF,Esswein LA,et al.The association of Atopy with a gain-of-function mutation in the alpha subunit of the Interleukin-4receptor[J].N Engl J Med,1997,337:1720-1725.
[73]Callard RE,Hamvas R,Chatterton C,etal.An interaction between the IL-4R alpha gene and infection is associated with atopic eczema in young children[J].Clin Exp Allergy,2002,32:990-993.
[74]oiso N,Fukai K,Ishii M.Interleukin-4 receptor alpha chain polymorphism Gln551Arg is associated with adult atopic dermatitis in Japan[J].Br J Dermatol,2000,142:1003-1006.
[75]Tanaka K,Sugiura H,Uehara M,etal.Lack of association between atopic eczema and the genetic variants of interleukin-4 and the interleukin-4 receptor alpha alpha chain gene:heterogeneity of genetic backgrounds on immunoglobulin E production in atopic eczema patients.[J]Clin Exp Allergy,2001,31:1522-1527.
[76]Hackstein H,HeckerM,Kruse S,etal.A novel polymorphism in the 5' promoter region of the human interleukin-4 receptor alpha-chain gene associated with decreased soluble interleukin-4 receptor protein levels[J].Immunogenetics,2001,53:264-269.
[77]Chavanas S,Bodemer C,Rochat A,etal.Mutations in SPINK5,encoding a serine protease inhibitor,cause Netherton syndrome[J].Nat Genet,2000,25:141-142.
[78]Walley AJ,Chavanas S,Moffatt MF,etal.Fene polymorphism en Netherton and common atopic disease[J].Nat Genet,2001,29:175-178.
[79]Kato A,Fukai K,oiso N,et al.Association of SPINK5 gene polymorphisms with atopic dermatitis in the Japanese population[J].Br J Dermatol,2003,148:665-669.
[80]Nishio Y,Noguchi E,Shibasaki M,et al.Association between polymorphisms in the SPINK5 gene and atopic dermatitis in the Japanese[J].Genes Immun,2003,4:515-517.
[81]Kusunoki T,okahuji I,Yoshioka T,et al.SPINK5 polymorphism is associater with disease secerity and food allergy in children with atopic dermatitis[J].J Allergy Clin Immunol,2005,115:636-638.
[82]Kabesch M,Carr D,Weiland SK,etal.Association between polymorphisms in serine protease inhibitor,kazal type 5 and asthma phenotypes in a large Germanpo pulation sample[J].Clin ExpAllergy,2004,34:340-345.
[83]RomanoA,De SantisA,RomitoA,etal Delayed hypersensitivity to aminopenicillins is related tomajorhistocompatibility complexgenes[J].Ann AllergyAsthma Immunol,1998,80(5):433-7.
[84]Yang J,Zou D,Qiao H L.Correlation of penicillin allergy and HLA-DRB genetic polymorphism[J].Chin Pharmacol Bull,2007,23(11):1497-501.
[85]Yang J,QiaoH L,Dong ZM.Polymorphisms of IL-13 and IL-4-IL13-SNPs in patients with penicillins allergy[J].Eur J Clin Pharmacol,2005,61(11):803-9.
[86]乔海灵,田鑫,郜娜.青霉素过敏病人特异性IgE和IgG抗体、相关细胞因子及其基因多态性[J].四川生理科学杂志,2005,27(4):182.
[87]Kumanogoh A,Marukawa S,Suzuki K,et al.Class Ⅳ semaphorin Sema4A enhances T cell activation and interacts with Tim-2[J].Nature,2002,419(6907):629-633.
[88]McIntire JJ,Umetsu DT,DeKruyff RH.TIM_1,a novel allergy and asthma susceptibility gene[J].Springer Semin Immunopathol,2004,25(3-4):335-348.
[89]李宝珠,刘光辉,高英.降钙素基因相关肽在哮喘中的作用[J].华中医学杂志,2006,(30)2:121.
[90]贯剑,郑湘瑞,周飞等.扶正固本法对特应质青少年基因表达的影响[J].上海中医药杂志,2008,42(4):49.
[1]王琦主编.中医体质学[M].北京:中国医药科技出版社,1995:11.
[2]王琦.中医体质学[M].北京:人民卫生出版社,2005:72.
[3]苏俊,王琦,钱会南,等.特禀体质特点初步研究[J].辽宁中医杂志,2008,35(6):824.
[4]灵枢经[M].北京:人民卫生出版社,1963:102.
[5]灵枢经[M].北京:人民卫生出版社,1963:71.
[6]灵枢经[M].北京:人民卫生出版社,1963:18.
[7]王琦.中医体质学[M].北京:人民卫生出版社,2005:72.
[8]隋·巢元方等著.诸病源候论(上册)[M].南京中医学院校释.北京:人民卫生出版社,1980,244.
[9]清·吴谦.医宗金鉴(上册)[M].北京:人民卫生出版社,1983:93.
[10]黄帝内经素问[M].北京:人民卫生出版社,1963:581.
[11]黄帝内经素问[M].北京:人民卫生出版社,1963:197.
[12]顾瑞金.变态反应病诊断治疗学[M].北京:北京医科大学中国协和医科大学出版社,1998:34.
[13]HowardTD,Meyers DA,Bleecker ER.Mapping susceptibilitygenes for allergic diseases[M].Chest,2003,123:363-368.
[14]Bahna SL.Factors determining development of allergy in infants[J].Allergy Proc,1992,13(1):21-25.
[15]李振吉主编.中医药常见名词术语辞典[M].北京:中国中医药出版社.2001,9:375
[16]宋·严用和.济生方[M].北京:人民卫生出版社.1956
[17]明·王肯堂.证治准绳[M].上海:上海古籍出版社.1991,4
[18]明·陈实功著.外科正宗[M].裘钦豪等点校.上海:上海科学技术出版社,1989,320.
[19]郭君双主编.中医儿科名著集成[M].北京:华夏出版社,1997,202.
[20]刘完素.中医古籍小丛书·素问玄机原病式[M].南京:江苏科学技术出版社.1985:274
[21]隋·巢元方等著.诸病源候论(下册)[M].南京中医学院校释.北京:人民卫生出版社,1982,1282.
[22]隋·巢元方等著.诸病源候论(上册)[M].南京中医学院校释.北京:人民卫生出版社,1980,244.
[23]刘完素.中医古籍小丛书·素问玄机原病式[M].南京:江苏科学技术出版社.1985:274
[24]明·董宿辑录.奇效良方[M].天津:天津科学技术出版社.2003:101.
[25]明·张景岳.景岳全书[M].北京:人民卫生出版社.1967:320.
[26]隋·巢元方等著.诸病源候论(下册)[M].南京中医学院校释.北京:人民卫生出版社,1982,1282.
[27]唐·孙思邈.备急千金要方[M].沈阳:辽宁科学技术出版社.1997
[28]清·陈士铎.辨证录[M].北京:人民卫生出版社.1965:81
[29]明·张介宾著.景岳全书[M].北京:人民卫生出版社,1991:651.
[30]明·王肯堂辑.证治准绳[M].上海:上海科学技术出版社,1959,365.
[31]清·吴谦等编.医宗金鉴(下册)[M].北京:人民卫生出版社,1985:1997.
[32]清·吴谦等编.医宗金鉴(下册)[M].北京:人民卫生出版社,1985:1889.
[33]清·方隅.医林绳墨[M].北京:商务印书馆.1957:120.
[34]清·陈士铎.辨证录[M].北京:人民卫生出版社.1965:81.
[35]明·张介宾著.景岳全书[M].北京:人民卫生出版社,1991:651.
[36]隋·巢元方等著.诸病源候论(上册)[M].南京中医学院校释.北京:人民卫生出版社,1980,315.
[37]吴宏东等.过敏康Ⅱ号胶囊对AsAb阳性大鼠睾丸Bcl-2、Bax表达的影响的研究[J].北京中医药大学学报.2007.32(3):9.
[38]张骏,翁福海.保肺祛敏冲剂抗过敏介质实验及抗乙酰胆碱收缩豚鼠离体回肠实验研究[J].天津医科大学学报.1999,5(4):69.
[39]张曼,任映,宋崇顺,等.鼻舒滴丸抗过敏作用及机理分析[J].中国中药杂志.2003,28(6):540.
[40]许利平,周丽娟,王红星,等鼻康胶囊对免疫功能的影响[J].四川中医,2005,23(6):23.
[41]宋光熠,张一红,李杰,等.消风止痒颗粒剂药理作用的实验研究[J].中成药,1995,17(12):30.
[42]许德金,王琦,许爱兰,等.治喘合剂治疗支气管哮喘的临床和实验研究[J]江苏中医,1995,16(5):44.
[43]宫昌,官凌涛,高志刚,等.消疹胶囊的药效学研究[J].中医药学报,1997,(3):54.
[44]刘守义,王义明.抗敏灵抗过敏作用的实验研究[J].中成药,1992,14(1):31.
[45]蔡宛如,钱华,朱渊红,等.芍药甘草汤平喘和抗过敏作用的实验研究[J].中国中西医结合急救杂志,2000,7(6):314.
[46]阮岩,冈本美孝,松崎全成.麻黄汤抗过敏作用的实验[J].中药新药与临床药理,2002,13(3):152.
[47]戴岳,詹亚玲,毕培曦,等.熟地黄和生地黄配伍的四物汤抗过敏作用的研究[J].中医药学刊,2002,20(5):59.
[48]张京力,韩兆丰,朱丹,等.麻黄连翘赤小豆汤及其加减方止痒作用的实验研究[J].辽宁中医杂志,1996,23(1):44.
[49]金亚宏,曹秀芳,李兰芳,等.茵陈五苓散抗变态反应作用研究[J].中国实验方剂学杂志,1999,5(2):49.
[50]肖洪彬,夏晓晖,朴赞斗,等.消风散主要药效学及拆方研究[J].中国实验方剂学杂志,1999,5(4):21.
[51]黄德斌.鬼箭羽70%提取物对速发型和迟发型变态反应抑制作用的实验研究[J].中国药理学报,2003,19(6):586.
[52]江俊,邴飞虹,蒋冠斌.地乌总甙抗炎及抗过敏作用的实验研究[J].中药药理与临床,1996,(5):20.
[53]徐涛,于庆海.北豆根总碱的抗变态反应作用[J].中药药理与临床,1996,(4):27.
[54]李振伟,于桂华.黄芩甙.枳壳治疗过敏性疾病的实验研究[J].实用药物与临床,2005,8(增刊):32.
[55]周文华,黄杞叶的抗过敏作用[J].国外医学·中医中药分册,1996,18(2):35.
[56]寺井美佐.郁金提取物组分的抗变态反应活性[J].国外医学·中医中药分册,1996,18(1):39.
[57]Ishinguro,K.一种实用且可重复和衡量鼠性过敏的方法:血压监测法及风仙花的抗过敏作用[J].国外医学·中医中药分册,1995,17(5):38.
[58]陈文,刘清华.抗过敏性鼻炎的中西药研究现状[J].石河子大学学报,2005,23(1):125.
[59]董自波,朱荃.应用血清药理学方法观察金荞麦片拮抗组胺引起的离体豚鼠回肠收缩作用[J].中国中医药科技,1999,6(3):149-150.
[60]甲斐久博.芫花的成分筛选及其抗过敏作用[J].国外医学:中医中药分册,2004,5:313.
[61]邴飞虹,江俊,郭晓林.银莲花胶囊抗过敏及抗炎作用研究[J].湖北中医学院学报,1999,1(2):55.
[62]马世平,瞿融,杭丙茜.蝉蜕的免疫抑制和抗过敏作用[J].中国中药杂志,1990,15(8):48.
[63]张骏,翁福海.保肺祛敏冲剂抗过敏介质实验及抗乙酰胆碱收缩豚鼠离体回肠实验研究[J].天津医科大学学报.1999,5(4):69.
[64]夏保芦,程标,涂宗苹.电针“内关”穴抗过敏性休克作用与脑内催产素含量的关系[J].针刺研究,2001,26(1):10.
[65]杨永清,崔龙萍,马淑兰,等.过敏性哮喘大鼠针刺血清的抗哮喘作用[J].上海针灸杂志,2002,21(1):34.
[66]林周杰,李光明,梁伟英,等.针刺结合埋线治疗过敏性鼻炎57例临床观察[J].四川中医,2004,22(5):
[67]姜锦林.中医药综合疗法治疗过敏性鼻炎120例体会[J].中华实用中西医杂志,2004,4(17):10.
[68]于学平,于春雷.针刺配合推拿法治疗过敏性鼻炎[J].中国针灸,1998,18(6):361.
[69]娄述.针刺加药治疗过敏性鼻炎31例[J].上海针灸,2000,19(2):33.
[70]郭龙,郑琳琴.抗过敏方保留灌肠治疗结肠过敏.50例中国中西医结合脾胃杂志,1999,7(4):252.
[71]孙淑芬.从瘀热论治过敏性紫癜102例[J].北京中医药大学学报。2001,24(6):70-71.
[72]张咏梅,活血化瘀法治疗过敏性紫癜临床观察[J].天津中医。1999,16(6):36-37.
[73]唐莉珍.辨证治疗过敏性紫癜60例[J].实用中医药杂志,2002,18(8):10.
[74]张小平,钱育寿.辨治过敏性紫癜6法[J].江苏中医药,2003,24(1):75
[75]阎丰书.清癜合剂治疗过敏性紫癜57例疗效观察[J].新中医,2003,11(38):29-30.
[76]闻名,王佩芳,马骏.抗敏解毒汤治疗过敏紫癜性肾炎30例[J].辽宁中医学院学报,1999,1(3):189.
[77]吴成山.过敏性鼻炎以痰论治初探[J].陕西中医,1996,17(12):54-4.
[78]王士贞.中医耳鼻喉科学[M].北京:中国中医药出版社,2003:125-127.
[79]张国雄.中药治疗过敏性鼻炎的体会[J].实用中医药杂志,2004,20(3):151.
[80]孙英.中药治疗荨麻疹的疗效观察[J].辽宁中医,2002,29(3):157.
[81]刘和平.自拟扶正祛风汤治疗荨麻疹265例临床观察[J].北京中医,2000,19(4):25.
[82]吴绪祥.抗敏汤治疗荨麻疹46例[J].河北中医,2000,22(2):127.
[83]刘志芬.自拟荨麻疹汤治疗慢性荨麻疹40例[J].四川中医,2000,18(8):34.
[84]许光兰.十味龙胆花颗粒治疗咳嗽变异型哮喘63例[J].中国中医药信息杂志,2002,9(1):72.
[85]Paranos S,Pravica V,Bonaci B,et al.Interleukin4,total,and allergenspecific immunoglobulin E antibodies in theblood of individuals with an atopic constitution[J].Srp Arh Celok Lek,1998,126:92-96.
[86]叶世泰.变态反应学[M].北京:科学出版社,1998:132,141,38.
[87]Cook PR,Nishioka GJ.Allergic rhinosinusitis in the pediatric population[J].Otolaryngol Clin North Am,1996,29(1):39-56
[88]王琦.骆庆峰.过敏体质的概念、形成与调控原理[J].北京中医药大学学报,2004,27(2):6.
[89]靳琦.王琦辨体-辨病-辨证诊疗模式[M].中国中医药出版社,2006:53.
[90]骆庆峰,王琦,牛欣.过敏康Ⅱ号胶囊对NIH雄性小鼠血清抗精子抗体的影响.北京中医药大学学报,2003,26(3):41-43.
[91]靳琦.王琦辨体-辨病-辨证诊疗模式[M].中国中医药出版社,2006:53.
[1]许以平.现代免疫学检验与临床实践[M].上海科学技术文献出版社,1999:92.
[2]苏贻心,郭履,陆培,等.过敏性鼻炎患儿IL-4、IL-10、IFN-γ水平的检测[J].上海免疫学杂志,1999,19(1):44.
[3郭续胜,王丽.过敏性鼻炎患者EOS、IL-4、IL-5的含量测定[J].齐鲁医学检验2004,15(2):61.
[4]孙勇,蒋捍东.哮喘合并过敏性鼻炎患者TH2类细胞因子水平研究[J].山东医药,2008,48(34):37.
[5]潘凯丽,白庆峰,黄莹,等.过敏性紫癜患儿血清白细胞介素-4、-6、-8及肿瘤坏死因子-α表达的意义[J].实用儿科临床杂志.2007.22(21):1632.
[6]李琦,金伯泉,陈艳妮.过敏性紫癜患者血清中IL-4水平明显升高[J].上海医学检验杂志,2000,15(3):160.
[7]张琴.过敏性紫癜的免疫学异常[J].国际免疫学杂志,2007,30(1):62-64.
[8]许以平,朱丽君,姚苏杭,等.过敏性哮喘患者血浆IL-4与IgE及嗜碱性细胞关系的研究[J].上海免疫学杂志,1997,17(2):86-87.
[9]钱起丰.遗传过敏性皮炎患者血清IL-4水平与IgE的关系[J].中华微生物学和免疫学杂志,1995,15:5.
[10]尹国华,李慧仙,张开明.荨麻疹患者血清可溶性细胞间粘附分子-1及白 介素-4含量的测定[J].中华皮肤科杂志,1997,30(6):402.
[11]Chindler CW.Series introduction:JAK-STAT signaling in human disease[J].J Clin Invest,2002,109(9):1133-1137.
[12]Pernis AB,Rothman PB.JAK-STAT signaling in asthma[J].J Clin Invest,2002,109(10):1279-1283.
[13]Sampath D,Castro M,Look DC.Constitutive activation of an epithelial STAT pathway in asthma[J].J Clin Invest,1999,103(9):1353-1361.
[14]Zhou L,Hershenson MB.Mitogenic signaling pathways in airway smoothmuscle[J].Respir Physiol Neurobiol,2003,137(2-3):295-308.
[15]Cazes E,Giron-Mickel J,Baouz S,et al.Novel anti-inflammatory effects of inhaled corticosteroid fluticasone propionate during lungmyofibroblastic differentiation[J].Immunol,2001,167(9):5329-5337.
[16]Trifilieff A,EI-Hasim A,Corteling R,et al.Abrogation of lung inflammation in sensitized STAT6-deficient mice is dependent on the allergen inhalation procedure[J].Br J Pharmacol,2000,130(7):1581-1588.
[17]Karrogawa Y,Lee HJ,Johnston JA,el al.Cutting edge:a conditionally active form of STAT6 can mimie certain effects of IL-4[J].Immunol,1998,161:1074-1077.
[18]Christodoulopoulos P,Cameron L,Nakamura Y,et al.Th2cytokineassociated transcription factors in atopic an nonatopic asthma:evidence for differential STAT6 expression[J].J Allergy Clin Immunol,2001,107:586-591.
[19]Matsurkura S,Stellato C,Plitt JR,et al.Activation of eotaxin genetranscription by NF-κB and STAT6 in human airway epithelial cells[J].Immunol,1999,163:6876-6883.
[20]Christodoulopoulos P,Cameron L,Nakamura Y,et al.Th2 cytokine associated transcription factors in atopic an nonatopic asthma:evidence for differential STAT6 expression[J].Allergy Clin Immunol,2001,107:586-591.
[21]Kelly-Welch AE,Hanson EM,Boothby MR,et al.Interleukin-4 and interleukin-13 signaling connections maps[J].Science,2003,300(5625):1527-1528.
[22]Pernis AB,Rothman PB.JAK-STAT signaling in asthma[J].Clin Invest,2002,109(10):1279-1283.
[23]Hayase H,Ishizu A,Ikeda H,etal.Aberrant gene expression by CD25+CD4+immunoregulatory T cells in autoimmune-prone rats carrying the human T cell leukemia virus type-Ⅰ gene[J].Lnt Lmmunol,2005,17:677-684.
[24]Trifilieff A,EI-Hasim A,Corteling R.Abrogation of lung inflammation in sensitized STAT6-deficient mice is dependent on the allergen inhalation procedure.British J Pharmacol,2000,130:1581-1588.
[25]曾佳,熊瑛国.信号转导和转录激活因子6基因与支气管哮喘的研究进展际[J].呼吸杂志,2007,27(17):1345.
[26]Brewster J L,Valoir T,DwyerN D,et al.An osmosensing signal transduction pathway in yeast[J].Science.1993,259(5102):1760- 1763.
[27]Ono K,Han JH.The p38 signal transduction pathway activation and function[J]Cell Signal,2000,12(1):1 - 6.
[28]Hale KK,Trollinger D,Rihanek M,et al.Differential expression and activation of p38 mitogen-activated protein kinase α,β,γ and δ in inflammatory cell lineages[J]J Immunol,1999,162(7):4246 - 4252.
[29]Kampen GT,Stafford S,Adachi T,et al.Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogenactivated protein kinase[J]Blood,2000,95(6):1911 - 1917.
[30]Ono K,Han J.The p38 signal transduction pathway:activation and function[J].Cell S ignal,2000,12(1):7- 13.
[31]Zarubin T,Han J.Activation and signaling of the p38MAP kinase pathway[J].Cell Res,2005,15(1):11 - 18.
[32]Dong X,Liu Y,Du M,et al Related Articles,Links Abstract,p38mitogen activated protein kinase inhibition attenuates pulmonary inflammatory response in a rat cardiopulmonary bypass model[J]Eur J Cardiothorac Surg,2006,30(1):77-84.
[33]Tudhope SJ,Finney - Hayward TK,Nicholson AG,et al.Differentmitogen - activated p rotein kinase - dependent cytokine responses in cells of the monocyte lineage[J].J Pharm acol Exp Ther,2008,324(1 ):306 - 312.
[34]黄翠萍,杨和平,张珍祥.p38蛋白激酶对支气管哮喘大鼠Th2类细胞因子表达的调控[J].中国病理生理杂志,2006,22(2):311-313.
[35]Ishizuka T,Okajima F,IshiwaraM et al.Sensitized mast cellsmigrate toward antigen:a response regulated by p38 mitogen activated protein kinase and Rho-associated coiled-coil-forming proteinkinase[J].Imm unol,2001,167(4):2298-304.
[36]Underwood DC,Osborn RR,Kotzer CJ et al.SB239063,a potent p38MAP kinase inhibitor,reduces inflammatory cytokine p roduction,airways eosinophil infiltration,and persistence[J].Pharmacol Exp Ther,2000,293(1):281 - 288.
[37]黄翠萍,张珍祥,徐永健.哮喘大鼠肺组织p38蛋白激酶表达的变化及地塞米松对其影响[J].中华微生物和免疫学杂志,2003,23(5):334-337.
[38]Underwood DC,Osborn RR,Kotzer CJ,et al.SB 239063,apotent p38 MAP kinase inhibitor,reduces inflammatory cytokine production,airway eosinophil infiltration,and persistence[J]Pharmacol Exp Ther,2000,293(1):281-288.
[39]刘志昂,阳丽华,高慧.cAMP、cGMP、IL-2、IL-6检测在过敏性鼻炎治疗中的临床意义[J].西北国防医学杂志,2008,29(6):463.
[40]王爱华,李全新.过敏性哮喘患者外周血IL-2、IL-4、IL-6和IL-8水平的变化[J].中国现代医学杂志2000,10(9):52.
[41]张琴.过敏性紫癜的免疫学异常[J].国际免疫学杂志,2007,30(1):62-64.
[42]李白恩,徐莉敏,陈意振.过敏性紫癜患儿血清sIL-2R、IL-6、IL-8及凝血功能的变化[J].中国优生与遗传杂志,2003,11(2):23.
[43]钱铸山,张春明,牛广华.过敏性紫癜患儿血清IL-6、IL-8、IL-10、TNF-α和免疫球蛋白水平研究[J].辽宁医学杂志,2006,20(1):6.
[44]余咏文,张强英,李鸣.小儿过敏性紫癜肾炎血清白细胞介素6、8水平变化及其临床意义[J].海南医学,2003,14(10):29-30.